Entity
Description
  • Value proposition

    Accelerating life-changing breakthroughs to cure, prevent and treat T1D and its complications

    JDRF is the only global organization with a strategic research plan to end type 1 diabetes (T1D). Our plan ensures that there will be an ongoing stream of life-changing therapies moving from development through to commercialization that lessen the impact of T1D. We want to keep people with T1D healthy and safe today until we reach our ultimate goal of a cure and universal prevention of T1D.

    JDRF collaborates with a wide spectrum of partners at every stage of the drug delivery pipeline and is the only organization with the scientific resources, regulatory influence, and a strategic plan to deliver a world without T1D. JDRF’s influence and leadership extends beyond funding research. We strategically partner with industry, governments, foundations, academia and clinicians, because curing T1D is a global, coordinated effort with JDRF at the center.

    For more information, please visit www.jdrf.org.

  • JDRF - Diabetes - Type 1 Diabetes Research, Advocacy, and Support

    JDRF leads the global Type 1 Diabetes support and research effort to keep people healthy and safe until we find a cure for the disease. Help create a world without T1D.

  • https://www.jdrf.org/
Corporate interactions BETA
Corporate TypeTweets Articles
Novo Nordisk
Novo Nordisk
Pharmaceutical, Pharmaceutical Manufacturing
Novo Nordisk
Pharmaceutical, Pharmaceutical Manufacturing
Other

5 Feb 2024


Nasdaq
Nasdaq
Finance, Financial Services
Nasdaq
Finance, Financial Services
Other

21 May 2019


Catapult.org
Catapult.org
National and local authorities, Civic & Social Organization
Catapult.org
National and local authorities, Civic & Social Organization
Other

10 Apr 2020


Sanofi
Sanofi
Pharmaceutical, Pharmaceutical Manufacturing
Sanofi
Pharmaceutical, Pharmaceutical Manufacturing
Other

7 Oct 2022


Similar entities
Loading...
Loading...
Social network dynamics